» Articles » PMID: 26143364

Differential Expression of Vascular Endothelial Growth Factor Angiogenic Factors in Different Endometrial Compartments in Women Who Have an Elevated Progesterone Level Before Oocyte Retrieval, During in Vitro Fertilization-embryo Transfer Treatment

Overview
Journal Fertil Steril
Date 2015 Jul 6
PMID 26143364
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the relationship between endometrial expressions of angiogenic factors around the time of embryo implantation and P level before oocyte retrieval during IVF-ET treatment.

Design: Retrospective study.

Setting: University Assisted Reproductive Unit.

Patient(s): Forty patients were recruited, 20 women with an elevated P level, and 20 women with a normal P level, into cancelled embryo transfer (ET) cycles.

Intervention(s): Endometrial biopsy samples were obtained from women who had an elevated or normal P level 7 days after human chorionic gonadotropin administration. The protein expression levels of VEGF-A, VEGF-C, and PLGF were examined using immunohistochemistry.

Main Outcome Measure(s): A semiquantitative analysis was performed using histochemical-score analysis of staining intensity in the luminal epithelium, glandular epithelium, and stroma, separately.

Result(s): Luminal epithelial expression of vascular endothelial growth factor (VEGF)-A, VEGF-C, and PLGF did not significantly differ in women with elevated or normal P levels before oocyte retrieval. Glandular epithelial expression of VEGF-A, VEGF-C, and PLGF was higher in women with elevated P levels, compared with those with normal P levels. A significantly higher stromal expression of VEGF-A and PLGF was found in women with elevated P levels.

Conclusion(s): A high P level before oocyte retrieval was associated with expression of VEGF angiogenic factors in glandular epithelium and stromal compartment around the time of embryo implantation. Our findings suggest that the lower implantation rates observed in this group of women may relate to decreased endometrial receptivity arising from altered expression of angiogenic factors.

Citing Articles

Exploring the potential benefits of growth hormone co-treatment on embryo quality in IVF: a randomized controlled open-label trial.

Tang Y, Li X, Hu C, Guan R, Wang Z, Zhang S Reprod Biol Endocrinol. 2025; 23(1):42.

PMID: 40089744 DOI: 10.1186/s12958-025-01374-3.


Placental growth factor mediates pathological uterine angiogenesis by activating the NFAT5-SGK1 signaling axis in the endometrium: implications for preeclampsia development.

Raja Xavier J, Okumura T, Apweiler M, Chacko N, Singh Y, Brucker S Biol Res. 2024; 57(1):55.

PMID: 39152497 PMC: 11330076. DOI: 10.1186/s40659-024-00526-w.


Up-regulated mRNA expression of VEGFA receptors (FLT1 and KDR) in placentas after assisted reproductive technology fertilization.

Mrozikiewicz A, Kurzawinska G, Walczak M, Skrzypczak-Zielinska M, Ozarowski M, Jedrzejczak P J Appl Genet. 2024; 65(3):531-540.

PMID: 38238614 PMC: 11310245. DOI: 10.1007/s13353-023-00823-2.


Overexpression of hypoxia-inducible factor 1α and excessive vascularization in the peri-implantation endometrium of infertile women with chronic endometritis.

Liu Z, Liu X, Li F, Sun Y, Yu L, Zhang W Front Endocrinol (Lausanne). 2022; 13:1001437.

PMID: 36531509 PMC: 9751377. DOI: 10.3389/fendo.2022.1001437.


Impact of blood levels of progesterone on the day of ovulation onset on clinical, laboratory and reproductive parameters of young patients undergoing assisted reproduction: a cross-sectional study.

Fernandez R, Barbosa C, Christofolini D, Sousa L, de Oliveira R, Bianco B Einstein (Sao Paulo). 2022; 20:eAO6896.

PMID: 35649054 PMC: 9126603. DOI: 10.31744/einstein_journal/2022AO6896.